BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8831842)

  • 1. Cisplatin metabolites and their toxicity on isolated cochlear outer hair cells in vitro.
    Saito T; Yamada T; Manabe Y; Yamamoto T; Saito H
    Acta Otolaryngol; 1996 Jul; 116(4):561-5. PubMed ID: 8831842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cisplatin ototoxicity: involvement of iron and enhanced formation of superoxide anion radicals.
    Dehne N; Lautermann J; Petrat F; Rauen U; de Groot H
    Toxicol Appl Pharmacol; 2001 Jul; 174(1):27-34. PubMed ID: 11437646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-administration of the neurotrophic ACTH(4-9) analogue, ORG 2766, may reduce the cochleotoxic effects of cisplatin.
    de Groot JC; Hamers FP; Gispen WH; Smoorenburg GF
    Hear Res; 1997 Apr; 106(1-2):9-19. PubMed ID: 9112103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative ototoxicity of cisplatin during acute and chronic treatment.
    Saito T; Aran JM
    ORL J Otorhinolaryngol Relat Spec; 1994; 56(6):315-20. PubMed ID: 7838482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic co-treatment with alpha-melanocyte stimulating hormone delays hearing loss caused by local cisplatin administration in guinea pigs.
    Wolters FL; Klis SF; de Groot JC; Hamers FP; Prieskorn DM; Miller JM; Smoorenburg GF
    Hear Res; 2003 May; 179(1-2):53-61. PubMed ID: 12742238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Similar pharmacokinetics and differential ototoxicity after administration with cisplatin and transplatin in guinea pigs.
    Saito T; Zhang ZJ; Yamada T; Yamamoto T; Shibamori Y; Saito H
    Acta Otolaryngol; 1997 Jan; 117(1):61-5. PubMed ID: 9039483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. X-ray microanalysis and ion microscopy of guinea pig cochlea and kidney after cisplatin treatment.
    Saito T; Aran JM
    ORL J Otorhinolaryngol Relat Spec; 1994; 56(6):310-4. PubMed ID: 7838481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Semiquantitative analysis by scanning electron microscopy of cochlear hair cell damage by ototoxic drugs.
    Saito T; Manabe Y; Honda N; Yamada T; Yamamoto T; Saito H
    Scanning Microsc; 1995 Mar; 9(1):271-80; discussion 280-1. PubMed ID: 8553022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of ozone (O
    Koçak HE; Taşkın Ü; Aydın S; Oktay MF; Altınay S; Çelik DS; Yücebaş K; Altaş B
    Eur Arch Otorhinolaryngol; 2016 Dec; 273(12):4153-4159. PubMed ID: 27221387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility of mouse cochlear hair cells to cisplatin ototoxicity largely depends on sensory mechanoelectrical transduction channels both Ex Vivo and In Vivo.
    Maruyama A; Kawashima Y; Fukunaga Y; Makabe A; Nishio A; Tsutsumi T
    Hear Res; 2024 Jun; 447():109013. PubMed ID: 38718672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cisplatin-induced ototoxicity: morphological evidence of spontaneous outer hair cell recovery in albino guinea pigs?
    Cardinaal RM; de Groot JC; Huizing EH; Veldman JE; Smoorenburg GF
    Hear Res; 2000 Jun; 144(1-2):147-56. PubMed ID: 10831873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronotolerance for cisplatin ototoxicity in the rat.
    Bielefeld EC; Markle A; DeBacker JR; Harrison RT
    Hear Res; 2018 Dec; 370():16-21. PubMed ID: 30253329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cisplatin and oxaliplatin are toxic to cochlear outer hair cells and both target thioredoxin reductase in organ of Corti cultures.
    Dammeyer P; Hellberg V; Wallin I; Laurell G; Shoshan M; Ehrsson H; Arnér ES; Kirkegaard M
    Acta Otolaryngol; 2014 May; 134(5):448-54. PubMed ID: 24702224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cisplatin ototoxicity and otoprotection with sodium salicylate.
    Hyppolito MA; de Oliveira JA; Rossato M
    Eur Arch Otorhinolaryngol; 2006 Sep; 263(9):798-803. PubMed ID: 16758221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ototoxicity of the new platinum anticancer agent TRK-710 in comparison with cisplatin.
    Saito T; Manabe Y; Saito H
    ORL J Otorhinolaryngol Relat Spec; 1995; 57(5):250-5. PubMed ID: 8587776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The intravenous administration of skin-derived mesenchymal stem cells ameliorates hearing loss and preserves cochlear hair cells in cisplatin-injected mice: SMSCs ameliorate hearing loss and preserve outer hair cells in mice.
    Tsai SC; Lin FC; Chang KH; Li MC; Chou RH; Huang MY; Chen YC; Kao CY; Cheng CC; Lin HC; Hsu YC
    Hear Res; 2022 Jan; 413():108254. PubMed ID: 34020824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Research progress on mechanism of cisplatin ototoxicity and protective agents against the ototoxic effects].
    Liao YJ; Tang H
    Sheng Li Ke Xue Jin Zhan; 2003 Jul; 34(3):266-9. PubMed ID: 14628479
    [No Abstract]   [Full Text] [Related]  

  • 18. Intracochlear administration of thiourea protects against cisplatin-induced outer hair cell loss in the guinea pig.
    Ekborn A; Laurell G; Ehrsson H; Miller J
    Hear Res; 2003 Jul; 181(1-2):109-15. PubMed ID: 12855369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential vulnerability of basal and apical hair cells is based on intrinsic susceptibility to free radicals.
    Sha SH; Taylor R; Forge A; Schacht J
    Hear Res; 2001 May; 155(1-2):1-8. PubMed ID: 11335071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing cisplatin-induced ototoxicity and otoprotection in whole organ culture of the mouse inner ear in simulated microgravity.
    Tropitzsch A; Arnold H; Bassiouni M; Müller A; Eckhard A; Müller M; Löwenheim H
    Toxicol Lett; 2014 Jun; 227(3):203-12. PubMed ID: 24709139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.